Current flow cytometry (FCM) reagents and instrumentation allow for the measurement of an
unprecedented number of parameters for any given cell within a homogenous or …

Non‐coding RNAs (ncRNAs) have been emerging players in cell development,
differentiation, proliferation and apoptosis. Based on their differences in length and structure …

Most consensus leukemia & lymphoma antibody panels consist of lists of markers based on
expert opinions, but they have not been validated. Here we present the validated EuroFlow …

Introduction Infiltration of breast tumors by tumor-infiltrating lymphocytes (TIL) has been
associated with sensitivity to anthracycline-based chemotherapy. However, it is unclear …

Early T‐cell precursor acute lymphoblastic leukaemia (ETP‐ALL) is a recently identified
subtype of T‐ALL with distinctive gene expression and cell marker profiles, poor response to …

Flow Cytometry of Hematological Malignancies Flow cytometric analysis is often integral to
the swift and accurate diagnosis of leukemias and lymphomas of the blood, bone marrow …

Background CD56 expression has been associated with a poor prognosis in lymphoid
neoplasms, including T-cell acute lymphoblastic leukemia (T-ALL). MicroRNAs (miRNAs) …

Recent evidence has shown that deregulated expression of members of the micro RNA‐29
(miR‐29) family may play a critical role in human cancer, including hematological …

T-cell acute lymphoblastic leukemia (T-ALL) is a rare, aggressive and heterogeneous
malignancy originating from T-cell precursors. The mechanisms of T-ALL pathogenesis …

NK-lymphoblastic leukemia/lymphoma (NK-LL) is an extremely rare hematopoietic tumor
consisting of natural killer (NK) precursor cells, and their lineage overlaps with T-cells …